Brain-Gut-Microbiota Interaction in IBS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-20

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Are you what you eat? How can dietary components influence microbial composition of the gut and function of the peripheral and central nervous system? The gut and brain is linked through complex mechanisms of sensorimotor functions of the immune system, the hypothalamic-pituitary-adrenal-axis, the enteric nervous system and microbiota.

In this project, a multitude of factors contributing to the bidirectional neurobiological communication along the brain-but-axis will be investigated. No disease of the brain-gut axis has been elucidated, therefore our investigations involves approaching a large span of components and processes involved in the axis. This study is carried out as a case-report study (baseline, IBS n=100, healthy controls n=40) followed by a dietary intervention (IBS-D n=60). Through multivariate analyses, the investigators will identify patterns of factors contributing to patient symptomatology and pathology, followed by big data analysis leading to stratification of sub-classification of irritable bowel syndrome (IBS).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome

NCT02565550

Irritable Bowel Syndrome

UNKNOWN PHASE4

Microbiota Profiling in IBS

NCT03720314

Irritable Bowel Syndrome Microbial Colonization Dietary Habits

COMPLETED

The Effect of Dietary Intervention on Symptoms, Epigenetics, and Gut Microbiota in IBS

NCT03306381

IBS - Irritable Bowel Syndrome

COMPLETED NA

A Clinical Trial Evaluating Diets for IBS

NCT05831306

Irritable Bowel Syndrome

UNKNOWN NA

Effects of Low FODMAP Diet on Leaky Gut

NCT04526808

Irritable Bowel Syndrome

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Data from deep phenotype characterization of 100 patients with IBS and 40 healthy age (between 18 and 65) and gender-matched controls will be collected between May 2019 and December 2021. Psychometric tests, questionnaires, biological samples (blood, faeces, saliva and GI biopsies from antrum, duodenum and sigmoid colon), assessment of gastric accommodation and emptying using transabdominal ultrasound, vagal activity, and functional and structural magnetic resonance imaging (MRI) of the brain, will be carried out. A subgroup of 60 patients with IBS-D will be further included in a 12-week low Fermentable Oligo-, Di-, Mono-saccharides And Polyols (FODMAP) dietary intervention-study to determine short and long-term effects of diet on symptoms, microbiota composition, molecular GI signatures, cognition and behavioural traits, and structural and functional brain signatures. Deep machine learning, prediction tools and big data analysis will be used for multivariate analysis allowing disease stratification and diagnostic biomarker detection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irritable Bowel Syndrome Functional Gastrointestinal Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

The study is an open, single-centre, case-control characterisation study, followed by open label dietary intervention for a subgroup of subjects with IBS-D. Exploratory trial.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

12 week lowFODMAP dietary intervention

Patients with IBS-D are enrolled in a 12 week strict lowFODMAP dietary intervention study.

Group Type EXPERIMENTAL

Dietary lowFODMAP intervention

Intervention Type OTHER

Twelve week strict lowFODMAP dietary intervention, involving restricted intake of fermentable carbohydrates (FODMAPs).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary lowFODMAP intervention

Twelve week strict lowFODMAP dietary intervention, involving restricted intake of fermentable carbohydrates (FODMAPs).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject must be between 18 and 65 years of age
* Fulfil the ROME-IV criteria for IBS

1. Had recurrent abdominal pain on average at least 1 day per week during the previous 3 months that is associated with alterations in bowel habits.
2. Duration at least six months.

Exclusion Criteria

* Pharmacological treatment affecting the GI-tract, including treatment for depression
* Organic disease:

1. coeliac disease
2. inflammatory bowel disease
3. neurological diseases
4. diabetes
5. active helicobacter pylori infection
6. polycystic ovary syndrome
* Treated with systemic antibiotics within the last 3 months
* Use painkillers regularly, other than paracetamol
* Pregnant
* Previous intestinal surgery (appendectomy is OK)
* Claustrophobic or have metallic implants that are not MR compatible
* Vegan or vegetarian
* Been travelling outside Europe within the last three weeks (or plan to travel in the nearest future)
* Probiotics or lowFODMAP-diet within the last three weeks
* Participation in any other simultaneous clinical study
* Inability to comprehend and respond to questionnaires or follow dietary guidance

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes